These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 28144133

  • 1. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E, Groenhof F, Hendrix R, van der Molen T, Sinha B, Kerstjens HA, Friedrich AW, Kocks JW.
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [Abstract] [Full Text] [Related]

  • 2. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
    Brownridge DJ, Zaidi STR.
    J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
    [Abstract] [Full Text] [Related]

  • 3. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
    Wilson R, Anzueto A, Miravitlles M, Arvis P, Haverstock D, Trajanovic M, Sethi S.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun; 10():985-93. PubMed ID: 26082623
    [Abstract] [Full Text] [Related]

  • 4. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J, Francis NA, White P, Gillespie D, Thomas-Jones E, Breen R, Kirby N, Hood K, Gal M, Phillips R, Naik G, Cals J, Llor C, Melbye H, Wootton M, Riga E, Cochrane A, Howe R, Fitzsimmons D, Sewell B, Alam MF, Butler CC.
    Trials; 2017 Sep 29; 18(1):442. PubMed ID: 28969667
    [Abstract] [Full Text] [Related]

  • 5. A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.
    Wilson R, Anzueto A, Miravitlles M, Arvis P, Faragó G, Haverstock D, Trajanovic M, Sethi S.
    Int J Chron Obstruct Pulmon Dis; 2011 Sep 29; 6():373-83. PubMed ID: 21760724
    [Abstract] [Full Text] [Related]

  • 6. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit.
    López-Campos JL, Abad Arranz M, Calero Acuña C, Romero Valero F, Ayerbe García R, Hidalgo Molina A, Aguilar Perez-Grovas RI, García Gil F, Casas Maldonado F, Caballero Ballesteros L, Sánchez Palop M, Pérez-Tejero D, Segado A, Calvo Bonachera J, Hernández Sierra B, Doménech A, Arroyo Varela M, González Vargas F, Cruz Rueda JJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Sep 29; 11():1171-8. PubMed ID: 27330285
    [Abstract] [Full Text] [Related]

  • 7. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
    Foda HD, Brehm A, Goldsteen K, Edelman NH.
    Int J Chron Obstruct Pulmon Dis; 2017 Sep 29; 12():209-214. PubMed ID: 28123293
    [Abstract] [Full Text] [Related]

  • 8. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ.
    Int J Chron Obstruct Pulmon Dis; 2016 Sep 29; 11():2851-2858. PubMed ID: 27920512
    [Abstract] [Full Text] [Related]

  • 9. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE, Shukla A, Muellerova H, Davis KJ.
    COPD; 2014 Sep 29; 11(5):521-30. PubMed ID: 24945236
    [Abstract] [Full Text] [Related]

  • 10. Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines.
    Reissig A, Mempel C, Schumacher U, Copetti R, Gross F, Aliberti S.
    Lung; 2013 Jun 29; 191(3):239-46. PubMed ID: 23564195
    [Abstract] [Full Text] [Related]

  • 11. An evaluation of early medication use for COPD: a population-based cohort study.
    Falk J, Dik N, Bugden S.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun 29; 11():3101-3108. PubMed ID: 27994449
    [Abstract] [Full Text] [Related]

  • 12. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
    van Velzen P, Ter Riet G, Bresser P, Baars JJ, van den Berg BTJ, van den Berg JWK, Brinkman P, Dagelet JWF, Daniels JMA, Groeneveld-Tjiong DRGL, Jonkers RE, van Kan C, Krouwels FH, Pool K, Rudolphus A, Sterk PJ, Prins JM.
    Lancet Respir Med; 2017 Jun 29; 5(6):492-499. PubMed ID: 28483402
    [Abstract] [Full Text] [Related]

  • 13. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M, Nakamura H, Takahashi S, Chubachi S, Sasaki M, Haraguchi M, Terai H, Ishii M, Fukunaga K, Tasaka S, Soejima K, Asano K, Betsuyaku T, Keio COPD Comorbidity Research (K-CCR) group.
    Int J Chron Obstruct Pulmon Dis; 2015 Jun 29; 10():1053-9. PubMed ID: 26082629
    [Abstract] [Full Text] [Related]

  • 14. Introduction of a PCT-based algorithm to guide antibiotic prescription in COPD exacerbation.
    Picart J, Moiton MP, Gaüzère BA, Gazaille V, Combes X, DiBernardo S.
    Med Mal Infect; 2016 Dec 29; 46(8):429-435. PubMed ID: 27609596
    [Abstract] [Full Text] [Related]

  • 15. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ, Boushey HA.
    Ann Am Thorac Soc; 2015 Nov 29; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [Abstract] [Full Text] [Related]

  • 16. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
    Daniels JM, Snijders D, de Graaff CS, Vlaspolder F, Jansen HM, Boersma WG.
    Am J Respir Crit Care Med; 2010 Jan 15; 181(2):150-7. PubMed ID: 19875685
    [Abstract] [Full Text] [Related]

  • 17. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
    Corti C, Fally M, Fabricius-Bjerre A, Mortensen K, Jensen BN, Andreassen HF, Porsbjerg C, Knudsen JD, Jensen JU.
    Int J Chron Obstruct Pulmon Dis; 2016 Jan 15; 11():1381-9. PubMed ID: 27382274
    [Abstract] [Full Text] [Related]

  • 18. Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelines.
    Roede BM, Bindels PJ, Brouwer HJ, Bresser P, de Borgie CA, Prins JM.
    Br J Gen Pract; 2006 Sep 15; 56(530):662-5. PubMed ID: 16953997
    [Abstract] [Full Text] [Related]

  • 19. Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD).
    Rockenschaub P, Jhass A, Freemantle N, Aryee A, Rafiq M, Hayward A, Shallcross L.
    J Antimicrob Chemother; 2020 Jan 01; 75(1):243-251. PubMed ID: 31598669
    [Abstract] [Full Text] [Related]

  • 20. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
    Liu H, Zheng D, Lin Y, Liu Z, Liang Z, Su J, Chen R, Zhou H, Wang Z.
    Pharmacol Res; 2020 Oct 01; 160():105095. PubMed ID: 32730904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.